Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intermittent Moxifloxacin in Non-Cystic Fibrosis Bronchiectasis
NCT07274020Phase 3Not yet recruiting
- Sponsor
- Assiut University
- Start
- Dec 2025
- Primary completion
- Dec 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of moxifloxacin in Non-cystic fibrosis bronchiectasis (NCFB), sponsored by Assiut University. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
moxifloxacin
03
Conditions
Non-cystic fibrosis bronchiectasis (NCFB)
Beyond the preview
Go deeper on NCT07274020.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07274020.